AKT1 and acute lymphoblastic leukemia: Although the predominant mechanism of PTEN inactivation may differ between human T-ALL and murine ATMKO T-LBL, 88% of these primary human samples demonstrated evidence of AKT activation, suggesting that there is a similar convergence towards AKT activation between human and murine T-ALL/LBL.